KLRK1 and cancer: The relevance of NKG2D in tumor surveillance has been demonstrated by in vivo experiments showing that overexpression of NKG2D ligands in cancer cells causes tumor rejection in mice (56, 57), and that NKG2D-deficient animals are defective in tumor surveillance in models of spontaneous malignancy (58).